Novartis is set to launch its one-off gene therapy Zolgensma for the ultra-rare muscle-wasting disease spinal muscular atrophy (SMA) in Germany at the start of July priced at 1,945,000 eu ...

While this can be a frustrating condition, it's essential to know that there are many available treatments that can help slow down or even reverse hair loss. This article will review male- and ...

incorporated in the year 1967, is a Mid Cap company (having a market cap of Rs 12,867.55 Crore) operating in Consumer Durables sector. Finolex Cables Ltd. key Products/Revenue Segments include ...